Bone marrow matching comes down to one thing: finding a donor whose HLA (human leukocyte antigen) proteins closely mirror the patient’s. Doctors test for specific HLA genes — typically 8 to 10 key markers — and the closer the match, the lower the risk of life-threatening complications like graft-versus-host disease (GVHD). A perfect 10/10 match from an unrelated donor or an HLA-identical sibling gives the best outcomes, but transplants can still succeed with 7/8 or even haploidentical (half-matched) donors when the clinical situation demands it.
If you’re here because you or a loved one needs a transplant, here’s the reality: only about 30% of patients find a fully matched donor within their family. The remaining 70% rely on unrelated donor registries like the National Marrow Donor Program (Be The Match), which has over 40 million registered donors worldwide. Even then, finding a match depends heavily on ethnic background, genetic rarity, and timing.
Step 1: HLA Typing — The Foundation of Every Match
Every bone marrow match starts with HLA typing, a blood or cheek swab test that maps out the proteins on the surface of your white blood cells. These proteins are how your immune system distinguishes “self” from “foreign.” If a donor’s HLA markers don’t align with the recipient’s, the transplanted cells may attack the patient’s body — or the patient’s residual immune system may reject the graft entirely.
Modern HLA typing uses high-resolution DNA sequencing (also called allele-level typing) rather than the older serological methods. This gives a far more granular picture of compatibility. The key HLA loci tested are:
| HLA Locus | Class | Role in Matching | Required for Match? |
|---|---|---|---|
| HLA-A | Class I | Presents intracellular antigens to CD8+ T cells | Yes — core locus |
| HLA-B | Class I | Presents intracellular antigens to CD8+ T cells | Yes — core locus |
| HLA-C | Class I | Ligand for NK cell receptors; antigen presentation | Yes — core locus |
| HLA-DRB1 | Class II | Presents extracellular antigens to CD4+ T cells | Yes — core locus |
| HLA-DQB1 | Class II | Associated with GVHD risk when mismatched | Often included (10/10 matching) |
| HLA-DPB1 | Class II | Permissive vs. non-permissive mismatches affect outcomes | Increasingly considered |
Since each person inherits one set of HLA genes from each parent (a haplotype), a full sibling has a 25% chance of being a perfect match. That’s the best-case scenario, and it’s why siblings are always tested first.
Step 2: Searching for a Donor
When no matched sibling exists, the transplant team initiates a search through unrelated donor registries. The process typically follows this hierarchy:
- HLA-identical sibling — Gold standard. 25% chance per sibling.
- Matched unrelated donor (MUD) — 8/8 or 10/10 match from a registry. The likelihood of finding one ranges from ~75% for patients of European descent to as low as 16–19% for Black or multiracial patients.
- Mismatched unrelated donor (MMUD) — 7/8 match. Associated with higher GVHD rates but viable with modern prophylaxis.
- Haploidentical (haplo) donor — A half-matched family member (parent, child, or sibling). Nearly every patient has at least one. Use of post-transplant cyclophosphamide has transformed haplo transplants into a mainstream option.
- Cord blood unit — Requires less stringent matching (4–6/6 at HLA-A, -B, -DRB1). Cell dose per kilogram is the limiting factor.
The search process itself takes an average of 3–6 months for unrelated donors, though urgent cases can be expedited. Time matters — disease progression during the search is a real concern.
Step 3: Confirmatory Testing and Donor Workup
Once a potential donor is identified, a confirmatory typing (CT) is performed to verify the match at high resolution. Additional testing includes:
- Crossmatch testing — Checks for preformed donor-specific antibodies (DSAs) in the recipient’s blood. Positive crossmatch significantly increases graft failure risk.
- ABO blood typing — Blood type doesn’t need to match for bone marrow transplants, but ABO incompatibility requires special management (red cell depletion, plasma depletion, or both).
- CMV status — Matching cytomegalovirus serostatus between donor and recipient reduces reactivation risk post-transplant.
- Infectious disease screening — Donors are tested for HIV, hepatitis B/C, syphilis, and other transmissible infections.
Why Ethnicity Matters So Much in Bone Marrow Matching
HLA genes are among the most polymorphic in the human genome — there are over 35,000 known HLA alleles. These alleles cluster within ethnic and geographic populations, which means your best chance of finding a match is typically someone from your own ancestry group.
This creates a profound disparity. Patients of European descent find 10/10 matched unrelated donors roughly 75% of the time. For patients of African, Hispanic, Native American, or mixed-race backgrounds, that number plummets to under 20% in some groups. This is one of the strongest arguments for diversifying donor registries — and why haploidentical transplantation has been such a game-changer for underrepresented populations.
What Happens When There’s No Perfect Match?
A decade ago, not finding a fully matched donor could be a death sentence. That’s no longer the case. Three advances have fundamentally changed the landscape:
- Post-transplant cyclophosphamide (PTCy) — Selectively destroys alloreactive T cells after transplant, dramatically reducing GVHD in haploidentical and mismatched transplants. Studies show haplo-PTCy outcomes now rival matched unrelated donor transplants for many diseases.
- T-cell depletion strategies — Removing donor T cells (ex vivo or in vivo with anti-thymocyte globulin) reduces GVHD risk when using mismatched donors.
- Permissive mismatch algorithms — For HLA-DPB1, researchers have identified “permissive” mismatches that don’t increase GVHD or mortality, versus “non-permissive” mismatches that do. This allows smarter donor selection even with imperfect matches.
When to Talk to a Transplant Specialist
If you’ve been told you need a bone marrow transplant, HLA typing should begin immediately — ideally at diagnosis of a transplant-eligible disease. Early typing of siblings and early activation of unrelated donor searches buy time.
Ask your hematologist these specific questions:
- Have all my siblings been HLA-typed at high resolution?
- Has a preliminary search of the unrelated donor registry been run?
- Am I a candidate for a haploidentical transplant if no matched donor is found?
- Do I have any donor-specific HLA antibodies that could complicate matching?
- What is my disease-specific timeline — how quickly do we need to move?
Frequently Asked Questions
Can a parent be a bone marrow match for their child?
A parent is always a haploidentical (50%) match for their child but almost never a full match. With modern post-transplant cyclophosphamide protocols, haploidentical transplants from parents are routinely performed with good outcomes, especially when no fully matched donor is available.
Does blood type need to match for a bone marrow transplant?
No. Unlike organ transplants, ABO blood type compatibility is not required for bone marrow transplants. After engraftment, the recipient’s blood type will actually convert to the donor’s type. ABO-mismatched transplants require some extra processing but don’t significantly impact survival.
How long does it take to find a bone marrow match?
Sibling typing results come back in 1–2 weeks. Unrelated donor searches typically take 3–6 months from initial search to donor clearance and collection. For urgent cases, some centers can expedite the process to 6–8 weeks. Cord blood units can be shipped faster since they’re already banked.
Why is it harder for minorities to find a bone marrow match?
HLA types are inherited and cluster within ethnic groups. Donor registries are disproportionately composed of donors of European descent. Combined with greater HLA diversity in African and admixed populations, this means fewer potential matches. Organizations like Be The Match are actively working to recruit more diverse donors, but the gap remains significant.
What is an 8/8 or 10/10 match?
These numbers refer to how many HLA loci are tested and matched. An 8/8 match means all 8 alleles tested (2 each at HLA-A, -B, -C, -DRB1) are identical. A 10/10 match adds HLA-DQB1 to the panel. The higher the match score, the lower the risk of GVHD and graft failure. Most centers now aim for 10/10 when selecting unrelated donors.
